drugset / Trial / NCT06246786
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
NaSingle-groupOpen-labelTreatment
Summary
This will be a single arm, non-randomized, pre-surgical clinical trial of women with newly diagnosed triple negative breast cancer with high g-H2Ax (gamma H2AX antibodies) comparing changes in biomarkers from a diagnostic core needle biopsy to surgical pathology specimen or repeat core needle biopsy.
Timeline
- Start
- 2024-07-01
- Primary completion
- 2025-06-23
- Completion
- 2025-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 5 mg/kg | — |